HemoClear BV and Nigeria’s National Blood Service Agency (NBSA) are tackling blood scarcity with a breakthrough autologous transfusion technology, aimed at improving care for women during childbirth.
Backed by the Fund for Innovation in Development, this project turns cutting-edge solutions into action, where they’re needed most.
See how innovation is put into practice
